[Post-treatment follow-up of head and neck cancer patients] |
journalArticle |
2019 |
Graff, P.; Blanchard, P.; Thariat, J.; Racadot, S.; Lapeyre, M. |
Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort |
journalArticle |
2016 |
Blanchard, P.; Wong, A. J.; Gunn, G. B.; Garden, A. S.; Mohamed, A. S.; Rosenthal, D. I.; Crutison, J.; Wu, R.; Zhang, X.; Zhu, X. R.; Mohan, R.; Amin, M. V.; Fuller, C. D.; Frank, S. J. |
The 5000% case: a glimpse into the financial issue of lung cancer treatment |
journalArticle |
2016 |
Remon, J.; Bonastre, J.; Besse, B. |
Preface |
journalArticle |
2016 |
Heinze, G.; Michiels, S.; Posch, M. |
Joint model for left-censored longitudinal data, recurrent events and terminal event: Predictive abilities of tumor burden for cancer evolution with application to the FFCD 2000-05 trial |
journalArticle |
2016 |
Krol, A.; Ferrer, L.; Pignon, J. P.; Proust-Lima, C.; Ducreux, M.; Bouche, O.; Michiels, S.; Rondeau, V. |
surrosurv: An R package for the evaluation of failure time surrogate endpoints in individual patient data meta-analyses of randomized clinical trials |
journalArticle |
2018 |
Rotolo, F.; Paoletti, X.; Michiels, S. |
Flexible modeling of disease activity measures improved prognosis of disability progression in relapsing-remitting multiple sclerosis |
journalArticle |
2015 |
Le Teuff, G.; Abrahamowicz, M.; Wynant, W.; Binquet, C.; Moreau, T.; Quantin, C. |
Influence of the vocal cord mobility in salvage surgery after radiotherapy for early-stage squamous cell carcinoma of the glottic larynx |
journalArticle |
2015 |
Gorphe, P.; Blanchard, P.; Temam, S.; Janot, F. |
Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study) |
journalArticle |
2015 |
Raynaud, C.; Greillier, L.; Mazieres, J.; Monnet, I.; Mastroianni, B.; Robinet, G.; Fraboulet, G.; Dixmier, A.; Berard, H.; Lamy, R.; Letreut, J.; Lena, H.; Oliviero, G.; Botta, S.; Vergnenegre, A.; Borget, I.; Chouaid, C. |
Prognostic factors of successful on-purpose tumor biopsies in metastatic cancer patients included in the SHIVA prospective clinical trial |
journalArticle |
2017 |
Desportes, E.; Wagner, M.; Kamal, M.; Salomon, A. V.; Deniziaut, G.; Pierron, G.; Rouleau, E.; Jouffroy, T.; Le Tourneau, C.; Paoletti, X.; Servois, V. |
Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non-muscle-invasive bladder cancer and with low and intermediate EORTC-risk score |
journalArticle |
2019 |
Simon, M.; Bosset, P. O.; Rouanne, M.; Benhamou, S.; Radulescu, C.; Molinie, V.; Neuzillet, Y.; Paoletti, X.; Lebret, T. |
Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castration-resistant prostate cancer: A report from the PETRUS prospective study |
journalArticle |
2016 |
Massard, C.; Oulhen, M.; Le Moulec, S.; Auger, N.; Foulon, S.; Abou-Lovergne, A.; Billiot, F.; Valent, A.; Marty, V.; Loriot, Y.; Fizazi, K.; Vielh, P.; Farace, F. |
How individual participant data meta-analyses have influenced trial design, conduct, and analysis |
journalArticle |
2015 |
Tierney, J. F.; Pignon, J. P.; Gueffyier, F.; Clarke, M.; Askie, L.; Vale, C. L.; Burdett, S.; Cochrane, I. P. D. Meta-analysis Methods Group |
Long-term follow-up of TaG1 non-muscle-invasive bladder cancer |
journalArticle |
2015 |
Olivier Bosset, P.; Neuzillet, Y.; Paoletti, X.; Molinie, V.; Botto, H.; Lebret, T. |
Phase I trial of bortezomib daily dose: safety, pharmacokinetic profile, biological effects and early clinical evaluation in patients with advanced solid tumors |
journalArticle |
2018 |
Bahleda, R.; Le Deley, M. C.; Bernard, A.; Chaturvedi, S.; Hanley, M.; Poterie, A.; Gazzah, A.; Varga, A.; Touat, M.; Deutsch, E.; Massard, C.; Van De Velde, H.; Hollebecque, A.; Sallansonnet-Froment, M.; Ricard, D.; Taillia, H.; Angevin, E.; Ribrag, V.; Soria, J. C. |
Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma |
journalArticle |
2015 |
Izzedine, H.; Derosa, L.; Le Teuff, G.; Albiges, L.; Escudier, B. |
Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis |
journalArticle |
2016 |
De Ruysscher, D.; Lueza, B.; Le Pechoux, C.; Johnson, D. H.; O'Brien, M.; Murray, N.; Spiro, S.; Wang, X.; Takada, M.; Lebeau, B.; Blackstock, W.; Skarlos, D.; Baas, P.; Choy, H.; Price, A.; Seymour, L.; Arriagada, R.; Pignon, J. P.; Group, Rtt-Sclc Collaborative |
The 5000% case: a glimpse into the financial issue of lung cancer treatment |
journalArticle |
2016 |
Remon, J.; Bonastre, J.; Besse, B. |
Genome-wide copy number analyses of samples from LACE-Bio project identify novel prognostic and predictive markers in early stage non-small cell lung cancer |
journalArticle |
2018 |
Rotolo, F.; Zhu, C. Q.; Brambilla, E.; Graziano, S. L.; Olaussen, K.; Le-Chevalier, T.; Pignon, J. P.; Kratzke, R.; Soria, J. C.; Shepherd, F. A.; Seymour, L.; Michiels, S.; Tsao, M. S. |
Statistical approaches for evaluating body composition markers in clinical cancer research |
journalArticle |
2017 |
Bayar, M. A.; Antoun, S.; Lanoy, E. |
Impact of primary para-aortic lymphadenectomy on distant failure in locally advanced cervical cancer patients treated in the era of image-guided adaptive brachytherapy |
journalArticle |
2016 |
Chargari, C.; Mazeron, R.; Dunant, A.; Gouy, S.; Petit, C.; Maroun, P.; Uzan, C.; Annede, P.; Bentivegna, E.; Balleyguier, C.; Genestie, C.; Pautier, P.; Leary, A.; Lhomme, C.; Deutsch, E.; Morice, P.; Haie-Meder, C. |
Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease |
journalArticle |
2018 |
Danlos, F. X.; Voisin, A. L.; Dyevre, V.; Michot, J. M.; Routier, E.; Taillade, L.; Champiat, S.; Aspeslagh, S.; Haroche, J.; Albiges, L.; Massard, C.; Girard, N.; Dalle, S.; Besse, B.; Laghouati, S.; Soria, J. C.; Mateus, C.; Robert, C.; Lanoy, E.; Marabelle, A.; Lambotte, O. |
Reply to the letter to the editor 'Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy' by Siva et al |
journalArticle |
2015 |
de Baère, T.; Aupérin, A.; Deschamps, F.; Chevallier, P.; Gaubert, Y.; Boige, V.; Fonck, M.; Escudier, B.; Palussiére, J. |
Enjeux méthodologiques de la médecine de précision en oncologie |
journalArticle |
2017 |
Asselain, B.; Paoletti, X. |
Radiation-induced neurocognitive dysfunction in head and neck cancer patients |
journalArticle |
2017 |
De Felice, F.; Blanchard, P. |
Assessing head and neck cancer patient preferences and expectations: A systematic review |
journalArticle |
2016 |
Blanchard, P.; Volk, R. J.; Ringash, J.; Peterson, S. K.; Hutcheson, K. A.; Frank, S. J. |
Mutation-Independent Activation of the Anaplastic Lymphoma Kinase in Neuroblastoma |
journalArticle |
2016 |
Regairaz, M.; Munier, F.; Sartelet, H.; Castaing, M.; Marty, V.; Renauleaud, C.; Doux, C.; Delbe, J.; Courty, J.; Fabre, M.; Ohta, S.; Vielh, P.; Michiels, S.; Valteau-Couanet, D.; Vassal, G. |
Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancer |
journalArticle |
2016 |
Gouy, S.; Ferron, G.; Glehen, O.; Bayar, A.; Marchal, F.; Pomel, C.; Quenet, F.; Bereder, J. M.; Le Deley, M. C.; Morice, P. |
The decision-making capacity of elderly hospitalized patients: validation of a test on their choice of return home |
journalArticle |
2018 |
Romdhani, M.; Abbas, R.; Peyneau, C.; Koskas, P.; Houenou Quenum, N.; Galleron, S.; Drunat, O. |
Plasma miR-200b in ovarian carcinoma patients: distinct pattern of pre/post-treatment variation compared to CA-125 and potential for prediction of progression-free survival |
journalArticle |
2015 |
Kapetanakis, N. I.; Uzan, C.; Jimenez-Pailhes, A. S.; Gouy, S.; Bentivegna, E.; Morice, P.; Caron, O.; Gourzones-Dmitriev, C.; Le Teuff, G.; Busson, P. |
Equal access to innovative therapies and precision cancer care |
journalArticle |
2016 |
Buzyn, A.; Blay, J. Y.; Hoog-Labouret, N.; Jimenez, M.; Nowak, F.; Deley, M. C.; Perol, D.; Cailliot, C.; Raynaud, J.; Vassal, G. |
Forget lung, breast or prostate cancer: why tumour naming needs to change |
journalArticle |
2024 |
Fabrice André, Elie Rassy, Aurélien Marabelle, Stefan Michiels & Benjamin Besse |
Vocal fold mobility as the main prognostic factor of treatment outcomes and survival in stage II squamous cell carcinomas of the glottic larynx |
journalArticle |
2015 |
Gorphe, P.; Blanchard, P.; Breuskin, I.; Temam, S.; Tao, Y.; Janot, F. |
Mortality analyses in the updated French cohort of uranium miners (1946-2007) |
journalArticle |
2015 |
Rage, E.; Caer-Lorho, S.; Drubay, D.; Ancelet, S.; Laroche, P.; Laurier, D. |
Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
journalArticle |
2019 |
Schumacher, F. R.; Olama, A. A. A.; Berndt, S. I.; Benlloch, S.; Ahmed, M.; Saunders, E. J.; Dadaev, T.; Leongamornlert, D.; Anokian, E.; Cieza-Borrella, C.; Goh, C.; Brook, M. N.; Sheng, X.; Fachal, L.; Dennis, J.; Tyrer, J.; Muir, K.; Lophatananon, A.; Stevens, V. L.; Gapstur, S. M.; Carter, B. D.; Tangen, C. M.; Goodman, P. J.; Thompson, I. M., Jr.; Batra, J.; Chambers, S.; Moya, L.; Clements, J.; Horvath, L.; Tilley, W.; Risbridger, G. P.; Gronberg, H.; Aly, M.; Nordstrom, T.; Pharoah, P.; Pashayan, N.; Schleutker, J.; Tammela, T. L. J.; Sipeky, C.; Auvinen, A.; Albanes, D.; Weinstein, S.; Wolk, A.; Hakansson, N.; West, C. M. L.; Dunning, A. M.; Burnet, N.; Mucci, L. A.; Giovannucci, E.; Andriole, G. L.; Cussenot, O.; Cancel-Tassin, G.; Koutros, S.; Beane Freeman, L. E.; Sorensen, K. D.; Orntoft, T. F.; Borre, M.; Maehle, L.; Grindedal, E. M.; Neal, D. E.; Donovan, J. L.; Hamdy, F. C.; Martin, R. M.; Travis, R. C.; Key, T. J.; Hamilton, R. J.; Fleshner, N. E.; Finelli, A.; Ingles, |
New French Coverage with Evidence Development for Innovative Medical Devices: Improvements and Unresolved Issues |
journalArticle |
2016 |
Martelli, N.; van den Brink, H.; Borget, I. |
Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancer |
journalArticle |
2015 |
Nascimento, C.; Borget, I.; Al Ghuzlan, A.; Deandreis, D.; Hartl, D.; Lumbroso, J.; Berdelou, A.; Lepoutre-Lussey, C.; Mirghani, H.; Baudin, E.; Schlumberger, M.; Leboulleux, S. |
Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial |
journalArticle |
2018 |
Bahig, H.; Yuan, Y.; Mohamed, A. S. R.; Brock, K. K.; Ng, S. P.; Wang, J.; Ding, Y.; Hutcheson, K.; McCulloch, M.; Balter, P. A.; Lai, S. Y.; Al-Mamgani, A.; Sonke, J. J.; van der Heide, U. A.; Nutting, C.; Li, X. A.; Robbins, J.; Awan, M.; Karam, I.; Newbold, K.; Harrington, K.; Oelfke, U.; Bhide, S.; Philippens, M. E. P.; Terhaard, C. H. J.; McPartlin, A. J.; Blanchard, P.; Garden, A. S.; Rosenthal, D. I.; Gunn, G. B.; Phan, J.; Cazoulat, G.; Aristophanous, M.; McSpadden, K. K.; Garcia, J. A.; van den Berg, C. A. T.; Raaijmakers, C. P. J.; Kerkmeijer, L.; Doornaert, P.; Blinde, S.; Frank, S. J.; Fuller, C. D. |
Intramuscular administration of alfaxalone for sedation in rabbits |
journalArticle |
2015 |
Huynh, M.; Poumeyrol, S.; Pignon, C.; Le Teuff, G.; Zilberstein, L. |
Treatment of squamous cell carcinoma of the posterior pharyngeal wall: Radiotherapy versus surgery |
journalArticle |
2016 |
De Felice, F.; Blanchard, P.; Levy, A.; Nguyen, F.; Gorphe, P.; Janot, F.; Temam, S.; Tao, Y. |